Video

Dr Milena Murray: Maintaining HIV Viral Load Suppression Can Save Health Care Dollars

Several economic benefits stem from engaging in care soon after HIV transmission and maintaining viral load suppression, noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor, Midwestern University College of Pharmacy.

Less hospitalization, health care dollars spent, and missed days of work, as well as better outcomes, especially for patients engaged in care soon after transmission, are all economic benefits from maintaining viral load suppression when living with HIV, noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy who practices at Northwestern Medicine's Infectious Disease Center in Chicago.

Transcript

What are the economic benefits of maintaining viral load suppression?

There's a lot of literature confirming that patients with an undetectable viral load have less hospitalizations and better outcomes than patients with a detectable viral load. And patients that get into care early after transmission, so if we can diagnose them early in the disease course, they also spend less health care dollars overall, both indirect and directly.

Direct benefits to the patient with having that stronger immune system, they’re potentially going to the doctor less often, they're having less issues, no opportunistic infections. And then indirectly over the patient's lifetime, if they're feeling better and have a better immune system, they have less missed days of work.

Related Videos
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson chair in preventative cardiology, Tulane University School of Medicine
Screenshot of an interview with Shaun P. McKenzie, MD
Hans Lee, MD
Don M. Benson, MD, PhD, James Cancer Hospital
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Hans Lee, MD
Screenshot of an interview with Amir Ali, PharmD, BCOP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo